Xenon: no stranger to anaesthesia

Slides:



Advertisements
Similar presentations
The chemokine CCL2 activates p38 mitogen-activated protein kinase pathway in cultured rat hippocampal cells  Jungsook Cho, Donna L. Gruol  Journal of.
Advertisements

From: Propofol Limits Microglial Activation after Experimental Brain Trauma through Inhibition of Nicotinamide Adenine Dinucleotide Phosphate Oxidase Anesthes.
Jiang Wu, Bihua Bie, Hui Yang, Jijun J. Xu, David L
Curcumin Requires Tumor Necrosis Factor α Signaling to Alleviate Cognitive Impairment Elicited by Lipopolysaccharide Neurosignals 2013;21: DOI: /
Small temperature variations alter edaravone-induced neuroprotection of cortical cultures exposed to prolonged hypoxic episodes  S. Shibuta, S. Varathan,
Aprotinin, but not ε-aminocaproic acid and tranexamic acid, exerts neuroprotection against excitotoxic injury in an in vitro neuronal cell culture model 
Yutaka Oomura, Shuji Aou, Kouji Fukunaga  Pathophysiology 
O. Moriarty, L. Harrington, S. Beggs, S.M. Walker 
Volume 71, Issue 6, Pages (March 2007)
Effects of propofol and surgery on neuropathology and cognition in the 3xTgAD Alzheimer transgenic mouse model  F. Mardini, J.X. Tang, J.C. Li, M.J. Arroliga,
Volume 88, Issue 3, Pages (November 2015)
Alternative technique or mitigating strategy for sevoflurane-induced neurodegeneration: a randomized controlled dose-escalation study of dexmedetomidine.
Volume 21, Issue 2, Pages (August 1998)
C Dualé, C Frey, F Bolandard, A Barrière, P Schoeffler 
S. Picardi, M. F. Stevens, K. Hahnenkamp, M. E. Durieux, P. Lirk, M. W
Local anaesthetics inhibit signalling of human NMDA receptors recombinantly expressed in Xenopus laevis oocytes: role of protein kinase C  K Hahnenkamp,
Volume 58, Issue 2, Pages (August 2000)
Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord  Chih-Shung Wong,
Leukemia inhibitory factor (LIF) potentiates antinociception activity and inhibits tolerance induction of opioids  H.J. Tu, K.H. Kang, S.Y. Ho, H.C. Liou,
L. Tong, M. Cai, Y. Huang, H. Zhang, B. Su, Z. Li, H. Dong 
Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats  J.F. Perez-Zoghbi,
Volume 37, Issue 2, Pages (January 2003)
Hill-Aina Steffenach, Menno Witter, May-Britt Moser, Edvard I. Moser 
Acetylcholine-secreting cells improve age-induced memory deficits
Volume 144, Issue 5, Pages (March 2011)
B. Haelewyn, A. Yvon, J. L. Hanouz, E. T. MacKenzie, P. Ducouret, J. L
C. A. Deegan, D. Murray, P. Doran, P. Ecimovic, D. C. Moriarty, D. J
A. Dinse, K.J. Fo¨hr, M. Georgieff, C. Beyer, A. Bulling, H.U. Weigt 
L. Pain, A. Launoy, N. Fouquet, P. Oberling 
Glutamine protects articular chondrocytes from heat stress and NO-induced apoptosis with HSP70 expression  H. Tonomura, M.D., K.A. Takahashi, M.D., Ph.D.,
M. Naguib, D. L. Hammond, P. G. Schmid III, M. T. Baker, J. Cutkomp, L
Ibuprofen for neuroprotection after cerebral ischemia
Volume 10, Issue 19, Pages (October 2000)
Differential effects of halothane and sevoflurane on hypoxia-induced intracellular calcium transients of neonatal rat carotid body type I cells†   J.J.
The effect of hyaluronan on CD44-mediated survival of normal and hydroxyl radical- damaged chondrocytes  P. Brun, Ph.D., S. Panfilo, B.S., D. Daga Gordini,
Volume 23, Issue 1, Pages (April 2018)
Volume 11, Issue 2, Pages (April 2015)
Single sevoflurane exposure decreases neuronal nitric oxide synthase levels in the hippocampus of developing rats  X. Feng, J.J. Liu, X. Zhou, F.H. Song,
Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats  A Dahan, A Yassen, H Bijl, R Romberg, E Sarton, L.
Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury  Y. Hijazi, C. Bodonian, M. Bolon, F. Salord,
Effects of cardiopulmonary bypass on neurocognitive performance and cytokine release in old and diabetic rats  F. de Lange, J.M. Dieleman, B. Jungwirth,
Late preconditioning with isoflurane in cultured rat cortical neurones
Loss of surface N-methyl-d-aspartate receptor proteins in mouse cortical neurones during anaesthesia induced by chloral hydrate in vivo  A. LacKamp, G.-C.
Neuroprotective and neurotoxic properties of the ‘inert’ gas, xenon
Volume 20, Issue 4, Pages (September 2013)
Samina Hyder Haq, Abir Abdullah AlAmro  Clinical Nutrition Experimental 
Dario Brambilla, David Chapman, Robert Greene  Neuron 
Balancing paediatric anaesthesia: preclinical insights into analgesia, hypnosis, neuroprotection, and neurotoxicity  R.D. Sanders, D. Ma, P. Brooks, M.
Volume 50, Issue 3, Pages (May 2006)
Distinct long-term neurocognitive outcomes after equipotent sevoflurane or isoflurane anaesthesia in immature rats  T.M. Ramage, F.L. Chang, J. Shih,
Anoxic depolarization of rat hippocampal slices is prevented by thiopental but not by propofol or isoflurane  R. Sasaki, K. Hirota, S.H. Roth, M. Yamazaki 
Pharmacodynamic changes with vecuronium in sepsis are associated with expression of α7- and γ-nicotinic acetylcholine receptor in an experimental rat.
R.D. Sanders, N Patel, M Hossain, D Ma, M Maze 
IFN-τ inhibits IgE production in a murine model of allergy and in an IgE-producing human myeloma cell line  Mustafa G. Mujtaba, PhDa, Lorelie Villarete,
Hsp70 Gene Transfer by Adeno-associated Virus Inhibits MPTP-Induced Nigrostriatal Degeneration in the Mouse Model of Parkinson Disease  Zhizhong Dong,
Differential Responses of S100A2 to Oxidative Stress and Increased Intracellular Calcium in Normal, Immortalized, and Malignant Human Keratinocytes  Tong.
T.J. Rowley, A McKinstry, E Greenidge, W Smith, P Flood 
W. Y. Lee, C. J. Park, T. J. Shin, K. W. Yum, T. G. Yoon, K. S. Seo, H
Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat  J.L. Martin, D. Ma, M. Hossain, J. Xu,
Avshalom Shostak, Valery Wajsbrot, Lazaro Gotloib  Kidney International 
Valerie Künzi, Patrick A
Propofol causes neurite retraction in neurones
Qianli Zhuang, MD, PhD, Bruce Mazer, MD 
Cross-tolerance between spinal neostigmine and morphine in the rat
P.J. Moss, W. Huang, J. Dawes, K. Okuse, S.B. McMahon, A.S.C. Rice 
Sato Y. , Kobayashi E. , Hakamata Y. , Kobahashi M. , Wainai T
Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in.
Apoptotic neurodegeneration and spatial memory are not affected by sedative and anaesthetics doses of ketamine/medetomidine combinations in adult mice 
Chronic ethanol consumption does not affect action of propofol on rat hippocampal acetylcholine release in vivo  Inagawa G. , Sato K. , Kikuchi T. , Nishihama.
Hapten-Specific Tolerance Promoted by Calcitonin Gene-Related Peptide
Presentation transcript:

Xenon: no stranger to anaesthesia R.D. Sanders, N.P. Franks, M Maze  British Journal of Anaesthesia  Volume 91, Issue 5, Pages 709-717 (November 2003) DOI: 10.1093/bja/aeg232 Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

Fig 1 Xenon inhibits NMDA receptors in cultured rat hippocampal neurones. NMDA activates an inward current (in neurones clamped at –60 mV) with an EC50 concentration of 24 (±2) μM NMDA and a Hill coefficient of 1.2 (±0.1). Xenon inhibited the current by approximately 60%, but did not significantly change either the EC50 or Hill coefficient. Each data point represents the mean peak current from at least six cells. The inset shows typical current traces (at 100 μM NMDA) in the presence and absence of xenon. Reproduced with permission from Nature 396: 324 copyright 1998, Macmillan Publishers Ltd.12 British Journal of Anaesthesia 2003 91, 709-717DOI: (10.1093/bja/aeg232) Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

Fig 2 Dose-dependent effect of xenon vs injury produced by either NMDA (a), or glutamate (b), in vitro. Co-cultures of mouse neuronal-glial cells were treated with either NMDA, 250 mM (a) or glutamate, 100 mM (b) for 10 min during exposure to O2/CO2/Xenon/N2. The xenon and N2 concentrations were changed reciprocally such that their aggregate was 75% of 1 atm. After 6 h, the culture medium was harvested and assayed for LDH. Data are expressed as % mean (sem) (n=3) of LDH released into the medium over the 6-h period, normalized to LDH release when no xenon is present. Reproduced with permission from Anesthesiology.64 British Journal of Anaesthesia 2003 91, 709-717DOI: (10.1093/bja/aeg232) Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

Fig 3 Dose-dependent neuroprotective effect of xenon in vivo on NMA-induced neuronal injury. Rats were injected with NMA 100 mg kg−1 s and destroyed 4 h later after exposure to air (NMA; n=7) or xenon (n=5–8). The arcuate nucleus was sectioned and stained with cresyl violet and the number of degenerated neurons (pyknotic nuclei surrounded by vacuolated cytoplasm) were counted (mean (sd)). *P<0.05, **P<0.01 compared with control. Reproduced with permission from Anesthesiology.64 British Journal of Anaesthesia 2003 91, 709-717DOI: (10.1093/bja/aeg232) Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

Fig 4 Neuromotor function after CPB. One, three, and twelve days after CPB, neuromotor function was assessed in rats using (i) rotating screen, (ii) a balance beam, and (iii) prehensile traction. A maximum score of 3 in each testing paradigm indicates normal performance so that aggregate normal performance will score ‘9’. Values are mean (sd), n=10. *P<0.05, **P<0.01, ***P<0.001 compared with CPB group at the same time point. Reproduced with permission from Anesthesiology.38 British Journal of Anaesthesia 2003 91, 709-717DOI: (10.1093/bja/aeg232) Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

Fig 5 Neurocognitive outcome as evaluated daily (from post-experimental days 3–12) after CPB by visual-spatial learning with the Morris water maze. The time for animals to find the platform (based on four trials at each time point) is referred to as the latency (mean (sem), n=10). Analysis of variance revealed that the Sham, CPB+MK801 or CPB+Xe group were significantly different from the CPB group statistically (CPB vs Sham: F=18.2, P<0.0001; CPB vs CPB+MK801: F=20.7, P<0.0001; CPB vs CPB+Xe: F=21.6, P<0.0001). Repeated measures with Student–Newman–Keuls, followed by analysis of variance, shows a significant difference when compared with the CPB group at the third and fourth postoperative day. Reproduced with permission from Anesthesiology.38 British Journal of Anaesthesia 2003 91, 709-717DOI: (10.1093/bja/aeg232) Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

Fig 6 Spatial memory after CPB. Twelve days after CPB, animals were subjected to a probe trial for 60 s, in which there was no platform present. The percentage of time spent in the quadrant of the former platform position was obtained as a measure of spatial bias. Animals in the Sham and CPB+Xe groups spent a longer period in the quadrant of the former platform, which indicates they have better spatial memory function than the other groups. The results are mean (sd) (n=10). *P<0.05, **P<0.01 compared with CPB group. †P<0.05 compared with CPB+Xe group. Reproduced with permission from Anesthesiology 302.38 British Journal of Anaesthesia 2003 91, 709-717DOI: (10.1093/bja/aeg232) Copyright © 2003 British Journal of Anaesthesia Terms and Conditions

Fig 7 Concentration or dose–response effects of xenon, nitrous oxide and ketamine on the number of c-Fos-positive neurons in the posterior cingulate and retrosplenial cortices. Rats were exposed to increasing doses or concentrations of three anaesthetics, which antagonize the NMDA receptor. Rats were destroyed and brains harvested and prepared for c-Fos immuno-staining. MK 801 is included as a known positive control for the production of a c-Fos immunohistochemical lesion in the posterior cingulate and retrosplenial cortices. Results are shown as mean (sem). *P<0.05; **P<0.01 vs control. Reproduced with permission from the Br J Anaesth.37 British Journal of Anaesthesia 2003 91, 709-717DOI: (10.1093/bja/aeg232) Copyright © 2003 British Journal of Anaesthesia Terms and Conditions